DatasetName,INF2_S(1158) INF2_S(1194) INF2_S(1201) INF2_S(1204) INF2_S(351) INF2_S(359) INF2_S(369) INF2_T(1199) INF2_T(1206),INF2_S(1032) INF2_S(1042) INF2_S(1044) INF2_S(1077) INF2_S(1147) INF2_S(1149) INF2_S(1183) INF2_S(1188) INF2_S(1192) INF2_S(1202) INF2_S(1227) INF2_S(1228) INF2_S(1229) INF2_S(1237) INF2_S(2) INF2_S(372) INF2_S(586) INF2_S(589) INF2_T(1054) INF2_T(1179) INF2_T(1187) INF2_T(420)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,0.5312578714741181
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.4668387952369018,0.5260610512753833
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.5304340215018187
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.5088569211692615
HS2024_6_B_T3,,0.5297223357667468
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,0.4529705027263123,0.5289230649724741
FSO2013_Ratio M/L normalized Rep1,,0.545749252612315
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.4602555935219951,0.5346206592558593
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.4535385064083923,0.536292839129779
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.45349871390289526,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,0.542053338111117
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,0.5475654856341535
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,0.545222607840599
EP2017_Untreated R#4 normalized log2 ratio,0.5357994428057361,0.5602815546333361
WZ2023_Pu_010_30min,0.43571845224209427,0.5484706145582836
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.5461621529238327
RB2022_8_RecoveryEndurance,,0.5385585613576205
KBE2022_Log2_Ex_14_U,,0.5362659322620189
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.5296144073532715
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,0.4509846231423417,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,0.5330314174212847
AH2018_SILAC_MR_2_N,,0.538293527021647
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,0.5438114796455976
EP2017_Pervanadate R#3 normalized log2 ratio,0.37973779356521936,0.5271591336120655
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.4674599477665601,0.5275887778037147
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,0.5114995971924546
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.43811963410282145,0.5447897612058407
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.45325790331785193,
KBE2022_Log2_Ex_34_U,0.45089254691961966,0.535591207631409
WZ2023_Pu_005_10min,0.4398660435141426,0.5439090370354036
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.4524676081316649,0.5347902572391036
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.43736344686501155,0.5286413327352494
AH2018_SILAC_MR_2_X,,0.539070018868138
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.4610662250867626,0.5347281343424325
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.4118164069159083,0.5398922592177622
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,0.42743041952473715,0.528599445586018
AH2018_SILAC_3_X,,0.533202674240978
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,0.536544833645057
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,0.5391600472870823
AH2018_LFQ_1_C,,0.54526299642758
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.4506145410261326,0.5383668799577239
HS2024_3_B_N1,,0.5394766746839779
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.43399662716654425,0.5408363142464491
CK2022_11 40-1,0.4519578171309464,0.5350755729284477
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.5346108396497148
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.47595643610492794,0.5502197922598137
FSO2013_Ratio H/L normalized Rep2,,0.5483838182460897
WZ2023_Pu_005_20min,0.43975981527419816,0.5382072331663645
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.45978403265177953,0.5329809141608219
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,0.5486145578536827
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.54814341440322
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,0.5401728248401488
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,0.5358310057228066
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.45697706773611163,0.5714200449338781
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,0.4492763917314407,0.53630965029149
PG2020_Intensity Mock_10h_D,,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.36420825096579806,0.5391663439053349
RCJD2014_5min_1,0.46623347193827197,0.5103457043779985
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,0.5407010228474394
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.43621034997144975,0.5120248669486636
KBE2022_Log2_Ex_8_T,,0.5376509151579484
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,0.5368836055481055
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,0.54971419541809
CK2022_3 40-1,0.45025736843112824,0.5339953542487009
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,0.44025366526693,0.5365882173586796
ZQ2022_N2,0.4527076805192721,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.5182852617012523
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,0.5395178137934732
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.5344932054523409
YA2020_Reporter_intensity_Normal_No.1,0.43647772042274324,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.46859485113961735,0.5537851440794691
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,0.5469247080810032
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.454203495924489,0.5341702725293657
HS2024_8_I_T3,,
CF2017_EOC 3,,0.5305801407992179
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.4353342544709961,0.5385925646779376
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.4490325243805829,0.5341540293937213
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,0.4520129361624102,0.5472467209768215
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.5300582230458611
FSO2013_Ratio H/M normalized Rep2,,0.5284345726624615
RAM2015_Log2 A,,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,0.5478814956027384
KS2014_Intensity E15_2,0.4696642639847288,0.5555000560955246
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.45711330814430945,0.5174352974889929
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,0.5313531681541803
AH2018_SILAC_M_3_X,,0.529161391833961
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.45060302661947077,0.5351979824086102
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.541145857041708
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.4545689146464237,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5389387906309187,0.5622073108925633
HS2024_6_B_N1,,0.5325759208032855
KBE2022_Log2_Ex_27_T,0.4528194241161493,0.5380033257369601
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,0.4294433001948381,0.5378233839801753
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,0.532244700783841
AH2018_SILAC_IT_3_X,,0.5342691648246104
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.5128857872488015
FSO2013_Ratio M/L normalized Rep2,,0.5460307101551379
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.43224784166576585,0.5382270845678131
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.4487667755771918,0.5345254079317313
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.5248979678765558
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.540544028575547
DL2023_control-1,,
AR2021_ALG 10 μM,,0.5339573387362121
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.5294597139317969
EJN2021_4_Rest_Ins,,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.4457035539045244,0.5486326568989761
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.45290527742018294,0.5359226658561141
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.5300949570322774
JW2021_After_3,,
GF2025_P8_Sph,0.4646160996619786,0.5300622048183832
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.5360486919480855
CK2022_11 200-1,0.443606499300473,0.5335470887493393
CK2022_12 200-1,0.4455830885915846,0.5342540814907525
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.44379908375444516,0.5384623565283523
WZ2023_Su_010_20min,0.43640839656899677,0.5332196113031326
AH2018_TMTMS2_2_N,,0.5335264005311084
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.45321016652994867,0.5358101605728832
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,,0.5194205493797541
KS2014_Intensity N4,0.4479077665424267,0.5373188764974267
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,0.538199609575266
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.4456917603101886,0.5504787588757705
CK2022_14 200-1,0.446623899655478,0.5362843398814066
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.5224350906598205
AST2020_anti-CD3+PDL2.2,0.4534978192112734,
PG2020_Intensity Mock_10h_A,,0.5316993050506996
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,0.4438710355487467,0.5442657848955516
GF2025_P1_Sph,0.45495927372044176,0.5246772069837089
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.43171272331837174,0.5428059000718775
CF2017_EOC 1,,0.5439897816239851
CK2022_3 200-1,0.4496930922369729,0.5354176489317558
AH2018_LFQ_IT_3_C,,0.5350743245064509
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.48583657797369245,0.5293483568619848
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,0.5448529435241338
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,0.5366227929664948
RB2022_6_PreStrength,,
CK2022_2 40-1,0.44980926905151225,0.5342320825884552
RB2022_1_PostSprint,,
CK2022_4 200-1,0.4491529902775573,0.5353727717200448
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,,0.5159131654731555
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.435413330943202,0.5719150285505313
CR2017_Ratio Replicate 3.2,,0.5397101571851354
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.43471560962600403,0.5609252307639153
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,0.46191968217467355,0.5350398154737797
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.4473195566754595,0.5360505054035501
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.445957084675612,0.5228670229479175
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,0.448166258941965,0.5347295767294784
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.4355922323617912,0.5443863926487239
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.45503078442591705,0.5366170227545584
AMK2021_Ctrl_p1,0.45934012152648307,0.5385475411612922
AH2018_LFQ_IT_3_X,,0.5345568401843678
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,,0.5219591716154055
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,0.5360107330719042
AH2018_LFQ_M_1_N,,0.5476286613725858
KBE2022_Log2_Ex_27_U,0.4528240330659654,0.5363527991284992
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.530966328131974
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.43702418413669514,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.52993922668073
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,0.535917489106848
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5299052542656765
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.45171157944678936,0.5348728336280267
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,
HH2022_Reporter intensity 6,,0.5356966851637393
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,0.5313356724274192
GF2025_P3_Adh,0.4334978740100556,0.5466850695994295
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,0.5309872541107868
RM2024_Intensity D0-1___2,,
LY2019_P4+,,
KBE2022_Log2_Ex_19_U,,0.5378004786464415
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,0.5439345916586689
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.4439903616871384,
AST2020_Control,0.45362487639926713,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.46541167256365373,0.5614795594141067
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,0.5527694017047521
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.5375159367242875
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,0.43414108533015566,
HS2024_8_B_T2,,0.548645412301259
AH2018_LFQ_1_X,,0.5430722991155021
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.4814644774599487,0.5308473580610169
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.4395749218430351,0.530133655822122
HH2022_Reporter intensity 1,0.4521853675494728,0.5357436704915822
HH2022_Reporter intensity 2,0.4529797302167574,0.5358602615698069
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.46032267354807754,0.5264430150472857
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,0.5382795705664675
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.5261104970668895
AR2021_KD 72h,0.4519626680867492,0.5360780546867989
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.4506798383052028,0.5362819486115956
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.517221240342071
KBE2022_Log2_Ex_9_U,0.4513518220365985,0.5368851901038076
AH2018_SILAC_M_3_N,,0.5298105254302437
KBE2022_Log2_Ex_13_T,,0.5379881743213101
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,0.5227284371825018
CF2017_OSE 29,0.4465064476482663,0.5478803543640601
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,
RN2012_L12,,0.5396153011099566
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.5341919223743747
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,0.5345524367169514
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.45120582783372143,0.5349083535412752
RB2022_7_RecoveryEndurance,,0.5394953365536205
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.5179387647967467
FSO2013_Ratio H/M normalized Rep2___2,,0.5374233148321048
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.45415454604377486,0.5396538897689251
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.44583363827444583,0.549644926129159
RB2022_1_PreSprint,,
HS2024_4_I_N1,,0.5483518931047932
CK2022_7 200-1,0.44476571498912915,0.5315468614145045
CK2022_5 200-1,0.4444100535070886,0.5314973399925287
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,0.5580829427653794
FSO2013_Ratio H/L normalized Rep2___1,,0.5450979535664842
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,0.5468955644953426
AH2018_SILAC_MR_1_X,,0.5437976776057222
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.45312387946674004,0.5350881809428452
AH2018_SILAC_3_C,,0.5342001720056998
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.5360795480886408
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.5450524512287228
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.5288198802514456
FSO2013_Ratio H/L normalized Rep3,,0.5398803303118447
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,0.5336476723804122
KBE2022_Log2_Ex_9_T,0.4508325553567764,0.5366251203663827
AH2018_SILAC_IT_2_N,,0.5285007169772877
AH2018_SILAC_IT_1_X,,0.5334373003532078
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.46453154715358314,0.5507303415534112
WZ2023_Pe_025_20min,0.433039235975353,0.5442659550460124
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.5446531075012087
HS2024_4_I_N2,,0.5457351296472026
AH2018_TMTMS2_3_N,,0.5319207702491271
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.43808336824479543,0.5335633214394188
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.46714444436692326,0.5272280631072509
WZ2023_Su_025_10min,0.43430888794112044,0.5316799014830419
AH2018_LFQ_IT_4_X,,0.5331926259916392
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.43926868307871275,0.5374470783512074
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.42462404394216574,0.5349057156301166
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.47283126550396,0.5516452095827554
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.4156390583213033,0.5257805313420206
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,0.4532069402750877,0.49689642451654326
RN2012_L10,,
PG2020_Intensity 4h_C,,
EP2017_Mitotic R#3 normalized log2 ratio,0.3660048842636721,0.528344605076023
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.45367251703347694,0.540021425876825
RB2022_8_PostStrength,,0.5359070807053898
AH2018_SILAC_IT_2_X,,0.5331152591549887
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.4564172000900189,0.5325948384175654
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,0.5341478336022244
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,0.5414175866752159
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.4485138322964644,0.5362364368043324
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.35239543947488144,0.5367871583438486
GF2025_P9_Sph,0.43700088168386214,0.5399257157423664
CK2022_6 200-1,0.44411082452848755,0.5316036539050029
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.5169440718429215
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,0.5358694326856284
PG2020_Intensity 2h_D,,0.527488598543037
EP2017_Untreated R#3 normalized log2 ratio,0.42865050876446703,0.5526648170410314
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.44427886009831863,0.5312169432942022
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.46587376716276313,0.542116022977475
RB2022_7_PostEndurance,,0.5306649472364382
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,0.5488530869327997
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.3955946773789647,0.5301822864667822
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,0.5441422331419025
AH2018_SILAC_2_C,,0.5351259964378249
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.4546370537810957,0.5377860735930621
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,0.534262220738637
AMK2021_45I_p5,0.4893978251887952,0.5576609072553045
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,0.5401224526756341
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.5416872167667585
PG2020_Intensity CT_C,,0.5318697021701096
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.4529205725058117,0.5361791862652094
EP2017_Untreated R#3 log2 ratio,0.4318589161138294,0.5550104293837544
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.500329509141227,0.5579351371107468
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,0.5453172075176298
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.46356907279397436,0.5335400524368586
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,,0.5287417779714024
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.4513394589116256,0.5397483706900553
YA2020_Reporter_intensity_Normal_No.2,0.43394313496142817,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,0.5330365868872939
AMK2021_120R_p3,0.4375903208122589,0.5268924823586011
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.5476996969976302
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,0.5367255337351282
CK2022_2 16-1,,
RAM2015_Log2 B,,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,0.5409405793926892
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,0.5316421754010953
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,0.524042497015751
WZ2023_Su_025_30min,0.4330088953842165,0.535152145434431
AH2018_LFQ_4_N,,0.5410553759941824
CR2017_Ratio Replicate 1.2,0.39439166734441167,0.5326181839668048
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,0.4663234864314341,0.5465999230957451
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.44690972687361974,0.5378726950169345
AH2018_SILAC_M_1_X,,0.5311738205248815
RB2022_7_PreEndurance,,0.5486008102602244
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.44675552791106643,0.516335240272314
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.5216227870380572
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.4431453932646474,0.5550595441677653
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.4381816197929758,0.5325180985158178
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.5430502322160173
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.4345927041091013,0.5280457341267208
AH2018_LFQ_2_X,,0.5455246167144882
PG2020_Intensity 2h_B,,0.5322877102612232
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.46067763867990025,0.5506396930359408
GF2025_P3_Sph,0.45456497846044186,0.531255802259311
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.5304332189437093
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,0.5467417994332059
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.5294326575671349
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.46931368266419593,0.5412615816674655
ZQ2022_N1,0.4578489299420458,
LY2019_P6-,,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,,0.5452505502738546
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,0.5369483094825065
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,0.5537211972266468
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.4505906004132456,0.5348961287249764
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.5202933494448317
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.4349275858942553,0.5391781003251085
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,0.5336839775465688
FSO2013_Ratio H/L normalized Rep1,,0.5438116192842531
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,0.5573196901828289
CK2022_13 40-1,0.4488128050375964,0.5344996846623817
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,0.4237079717862661,0.532386826771518
RB2022_8_PreEndurance,,0.5510134446808699
HS2024_3_B_N2,,0.5314848693887946
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.38109711294291454,0.5281701842249336
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.4530435117014248,0.5094446356980646
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,0.5389541013769829
AH2018_LFQ_M_4_C,,0.542737123140861
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,0.5476862969374829
RN2012_H04,,
CK2022_6 40-1,0.45023274600753216,0.5347913055713324
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.4618449903748666,0.5374495323905901
LY2019_P3-,,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.43599019036139725,0.5408178825817268
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,0.45436805447543627,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,0.5296760726657919
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.437100836339034,0.5464235790914249
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.4461244534623387,0.576150685868034
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,0.5312458942665016
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.5183630561538456
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.5328578773571512
LY2019_P8+,,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,0.5331464426735837
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.5444993349582458
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.44966488196268156,0.5373107145333481
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.5518349532506501
LY2019_P2-,,
AH2018_LFQ_IT_1_X,,0.5303904801043644
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.432826009674836,0.5458015831152886
AST2020_Control.2,0.4540333759022942,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.4416885241314705,0.4930888330694444
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.4493088227385483,0.5345778915526068
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.4508916349829791,0.5511350192251148
HS2024_5_B_T2,,0.5475938248835829
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.4523138865491847,0.5339076789346313
AH2018_TMTMS3_3_N,,0.5193495634846548
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.5398004581908797
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.37980207311262587,0.5342326671007025
KBE2022_Log2_Ex_36_T,0.4514683159977975,0.5347487893662528
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.4324535992584665,0.530732736694246
KS2014_Intensity C2,0.4411202341523468,0.5412816369901384
FSO2013_Ratio H/L normalized Rep1___2,,0.5497247337577338
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.4545099425196713,0.5398043752531436
CK2022_9 200-1,0.44493127617804823,0.5330233277628607
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.4428194344085571,0.5326378593135448
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,0.543433466227082
RBK2021_1332T Late,,
LY2019_P1-,,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.4931800571312189,0.543398795831236
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,0.5564018053187201
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.47532111611868605,0.5446753524282432
ZQ2022_C3,0.4617901243456445,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.4507480716199732,0.5377253180797962
FSO2013_Ratio H/M normalized Rep3___2,,0.5238510463945609
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.4560574740521063,0.49815486209883625
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.44080213718037453,0.5370993935525988
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.4355933792213873,0.5336340160399223
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,0.5159844275177548
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,0.5428164694186339
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.537899177284418
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.5395041686031864
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,0.4792447568949309,0.5343781126676537
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,0.5372155838089308
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,0.5367778189120964
AR2021_KD 48h,0.44686071330622007,0.5234659411183261
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.4540811914441804,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.4341850656365556,0.5388411283582067
KBE2022_Log2_Ex_29_U,0.45341195259402434,0.5355389287478938
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,0.5488022011094699
AH2018_LFQ_IT_4_N,,0.5344831332531208
CK2022_15 200-1,0.4476186134801117,0.5358229058041767
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.44905874316458494,0.5368807069462753
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,0.5449563898384556
LY2019_P2+,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.44924856695708054,0.5360788257841809
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.4382760825788148,0.5361939054082511
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,0.5335493921665513
EP2017_Pervanadate R#1 normalized log2 ratio,0.42314153619688555,0.5340889578605745
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.43081926101842366,
KBE2022_Log2_Ex_44_U,0.4526765884151824,0.5364538311449422
WZ2023_Pe_010_20min,0.43591769803814034,0.5329796198692918
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.4442341076357006,0.5752151753819424
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.45584202554377423,0.5479526061963511
KS2014_Intensity C1,0.45105607197574116,0.5291492769821734
FSO2013_Ratio H/M normalized Rep3___1,,0.5314431602595285
AH2018_SILAC_M_3_C,,0.5304535304059521
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.5356751518754814
AH2018_SILAC_M_2_X,,0.5339366320784136
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.46203648062434943,0.5371542447574251
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.43116978022807273,0.5325159798535443
PG2020_Intensity 6h_C,0.4407754315657961,0.528598834145985
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.5483111813166057
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,0.5315032323167689
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,,
FSO2013_Ratio H/L normalized Rep3___2,,0.5325086843580921
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,0.5301359504573446
GF2025_P8_Adh,0.43449292307426346,0.5274704542193234
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.46261291577004204,0.5236404588441522
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,0.4801677263900835,0.5531113465846457
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.36517031051547266,0.5417647072118416
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,0.5573532397122066
CF2017_FTE 16,,0.5481294734738191
AR2021_L41 10 μM,,0.5212566468762218
CF2017_EOC 2,,0.5315938216060064
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,0.5300505767369523
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,0.5383051931206918
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,0.5113537635846975
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.45239718455536376,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,0.5295456470979979
AR2021_L41 1 μM,,0.5190999392738687
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,0.5323614152691948
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,0.5085968977654862
KS2014_Intensity C4,0.44458701927929084,0.5238449912265579
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.4518029829421195,0.5387454580232425
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.4636382280931841,0.5005093336779513
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,0.4713563572720406,0.5482810629931545
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.5489522442001961
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,0.5441785306964992
YA2020_Reporter_intensity_Cancer_No.2,0.43631450185766973,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,0.5280675445897035
WZ2023_Pu_025_10min,0.4369825007938055,0.531121130066997
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.44969230570360136,0.5891544022081573
FSO2013_Ratio M/L normalized Rep3___1,,0.5328865734742975
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.43831910649527805,0.5340723991969628
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.4364708563803984,0.5412757569857812
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.5359805866466675
KS2014_Intensity C6,0.44457632724623547,0.5415751641506157
ZQ2022_N3,0.4581251094627551,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.4515265953527528,0.5351384658338549
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.5119084251591278
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.4487253649688933,0.5349920499840011
AH2018_SILAC_IT_2_C,,0.5285128134992069
CK2022_5 40-1,0.4513570060246749,0.5350367274012213
AH2018_LFQ_3_X,,0.5440014572924442
UK2020_UA_3,,
LY2019_P7-,,
GF2025_P5_Adh,0.4538550301209092,0.5445064360021182
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5434414475066732
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,,0.5381102709211721
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,0.4616115244062999,
CR2017_Ratio Replicate 2.1,,0.5280681966982588
PG2020_Intensity CT_B,,0.5310384595044486
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.5391444704064517
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.4441340758873855,0.5650840302552197
AH2018_LFQ_3_C,,0.5457932745482429
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,0.46549608374730955,0.5453203416335047
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.547071714890034
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.47157760030141405,0.526299526689828
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.45304867770517354,0.535004897160353
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,0.4535262173241972,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,0.5428797137163792
HS2024_8_I_T1,,0.5459043223170892
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.37681047020944397,0.5435867647838071
AH2018_TMTMS2_1_X,,0.5299206985303516
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,0.5374582065656844
HH2022_Reporter intensity 4,,0.5352557628131758
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.44779375541314903,0.5349510815308819
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.5521017867453896
HS2024_4_I_T3,,
AH2018_SILAC_1_X,,0.5304006516743783
PG2020_Intensity 10h_B,,0.5243506687662908
AH2018_TMTMS3_1_X,,0.5182802447702272
CF2017_FTE 14,0.4480833208388423,0.5422058044895258
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.4432890838833396,0.5315745135784049
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,0.5354738990946895
EP2017_Untreated R#2 normalized log2 ratio,0.45772835060698713,0.5248025010470991
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.39709922776611034,0.5310603764253803
AS2011_Ratio H/L Normalized RNAi_2_1,,
